Immediate and acute adverse effects following transforaminal epidural XXXX injections with @entity619 .

@entity1 @entity1671 @entity1183 @entity111 @entity619 @entity22 @entity11637 @entity158 @entity10 @entity479
BACKGROUND: Transforaminal epidural @entity479 injections (TFESI) are widely used for the conservative treatment of @entity158 . The use of @entity619 in TFESIs is relatively new; therefore, immediate and acute adverse effects that it may cause are not fully updated. OBJECTIVE: To evaluate immediate and acute adverse effects following TFESI with @entity619 . STUDY DESIGN: Prospective, observational study. SETTING: A spine center affiliated with a rehabilitation hospital. METHODS: One hundred fifty consecutive @entity1 receiving TFESI for the management of radicular and axial spinal @entity158 at the cervical, lumbar, and sacral levels with @entity619 using fluoroscopic guidance with digital subtraction technology were enrolled. The occurrence of adverse effects in @entity1 in the 2-week time period following interventions was monitored through a set of questionnaires followed up by phone calls scheduled for 1 day, day 3, and day 14. Intensity and duration of side effects were recorded. RESULTS: Of the 150 @entity1 enrolled, 31 @entity1 (19.5%) experienced adverse effects within the first 30 minutes following the intervention. The most common adverse effects were @entity1183 and tingling in the limb, which developed in 19 @entity1 (11.95%) followed by perineal @entity111 that occurred in 7 cases (4.4%). @entity1 also reported experiencing adverse effects within the 3 days following intervention; most complained of @entity10 , @entity22 , @entity11637 , @entity1671 , and increased @entity158 . No major complications were noted. LIMITATIONS: The sample size enrolled might be too small to perceive possible rare side effects related to the procedure. The 2-week follow-up period is a limitation for evaluating late side effects. CONCLUSIONS: This study offers provision to interventionalists that TFESI with @entity619 when performed by experienced hands and with proper technique has minor self-limited transient adverse effects that can be easily managed. @entity1 should be made aware of these adverse effects and their management. Further larger studies are needed to validate the safe use of @entity619 and the safety of transforaminal epidural injections.
